| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| 未完成注册，暂无注册号 |
Ethics Committee of Suzhou Hongci Hematology Hospital |
Pure red cell aplasia |
Therapy Study |
Post-market |
2024-04-26 | 381 | Patient list |
| 未完成注册，暂无注册号 |
Ethics Committee of Suzhou Hongci Hematology Hospital |
SAA |
Therapy Study |
Post-market |
2024-04-26 | 398 | Patient list |
| 未完成注册，暂无注册号 |
Ethics Committee of Suzhou Hongci Hematology Hospital |
SAA |
Therapy Study |
Post-market |
2024-04-26 | 403 | Patient list |
| 未完成注册，暂无注册号 |
Ethics Committee of Suzhou Hongci Hematology Hospital |
Warm antibody type autoimmune hemolytic anemia |
Prognostic Study |
Post-market |
2024-04-19 | 400 | Patient list |
| 未完成注册，暂无注册号 |
Ethics Committee of Suzhou Hongci Hematology Hospital |
IDA |
Prognostic Study |
Post-market |
2023-06-20 | 423 | Patient list |